Chugai Pharmaceutical Co. Ltd.

In News

Chugai Pharmaceutical (OTCMKTS:CHGCY) Shares Gap Up - Still a Buy? - MarketBeat

MarketBeat - Dec 05, 2025

Chugai Pharmaceutical Co., Ltd. (TSE:4519) Stocks Shoot Up 26% But Its P/E Still Looks Reasonable - simplywall.st

simplywall.st - Nov 26, 2025

Rani Therapeutics signs up to $1.09 billion licensing deal with Japan's Chugai Pharma - Reuters

Reuters - Oct 17, 2025

AWS Collaborates with Chugai Pharmaceutical Co. on Quantum-Inspired and Constraint Programming Methods for Cyclic Peptide-Protein Docking - Amazon Web Services (AWS)

Amazon Web Services (AWS) - Oct 13, 2025

Message from the CEO | Company Outline | About Chugai | CHUGAI PHARMACEUTICAL CO., LTD. - chugai-pharm.co.jp

chugai-pharm.co.jp - Mar 06, 2025

Chugai and Gero Enter into Joint Research and License - GlobeNewswire

GlobeNewswire - Jul 07, 2025

Chugai to enhance kidney disease portfolio with Renalys - Pharmaceutical Technology

Pharmaceutical Technology - Oct 27, 2025

NEC and Chugai Pharmaceutical use AI to potentially enhance cancer treatment: Press Releases - NEC Global

NEC Global - Jun 18, 2025

Earnings To Watch: Chugai Pharmaceutical Co Ltd (TSE:4519) Reports Q2 2025 Result - Yahoo Finance

Yahoo Finance - Jul 23, 2025

Chugai to Construct a New Laboratory Building “UKX” to Strengthen Manufacturing Process Development Capabilities and Advance Environmental Initiatives toward TOP I 2030 - FirstWord Pharma

FirstWord Pharma - Jul 24, 2025

Chugai Sinks Most Since 1977 on Obesity Drug Disappointment - Bloomberg.com

Bloomberg.com - Aug 07, 2025

Chugai Pharmaceutical (OTCMKTS:CHGCY) Shares Gap Down - Should You Sell? - MarketBeat

MarketBeat - Dec 03, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment